Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...

The research also predicts inflammatory bowel disease diagnoses will likely double in Aotearoa in the next 20 years.

To evaluate the therapeutic value of mirikizumab in IBD, researchers conducted a systematic review and meta-analysis of ...

Crohn’s Disease and Ulcerative Colitis affects more than a million people including their families in Southern California ...

For an accessible version of this Press Release, please visit On track for 30% operating profit margin by 2027 in line with ...

Women with the autoimmune diseases rheumatoid arthritis, lupus or systemic sclerosis may have a higher rate of death related to cardiovascular disease than men with the autoimmune diseases, according ...

CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ...

Women with any of three common types of autoimmune disease may face a higher rate of death linked to heart disease and stroke ...

Learn more about whether Option Care Health, Inc. or Premier, Inc. is a better investment based on AAII's A+ Investor grades, ...